Advisory Board and Editors Cell Biology

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Dario T Bonetta

Associate professor in Faculty of Science at Ontario Tech University. Co-founder Metasys Genomics Corp. Interests include: biologically based materials derived from plant and bacterial sources; plant and animal development; inter-kingdom signalling and cell communication.

Ebba Brakenhielm

INSERM Tenured Researcher in the field of Cardiovascular Research, currently focusing on therapeutic angiogenesis with polymer-based targeted growth factor delivery.

PhD in Tumor Biology (Pr Yihai Cao, Karolinska Institutet, Sweden), and expertise in Adipose tissue angiogenesis. Postdoc at UCLA (Pr Lily Wu) in molecular imaging and tumor lymphangiogenesis field.

Member of European Vascular Biology Organisation, French society for Cardiovascular Research, French society for Angiogenesis Research.

Saverio Brogna

Lecturer and principal investigator at the School of Biosciences of the University of Birmingham, UK. Interested in eukaryotic gene expression and particularly in understanding the links between RNA processing and translation.

At present his group research focuses on understanding nonsense mediated mRNA decay (NMD) and its links with pre-mRNA splicing.

Paul S. Brookes

Professor of Anesthesiology at University of Rochester Medical Center. PhD in Biochemistry from Cambridge University (UK) and post-doctoral training at the University of Alabama at Birmingham. Research program in mitochondria, cardiac ischemia, and cardioprotective therapies.

Daniela Brünnert

My current research is related to autoimmune diseases, where we develop and express and characterize specific AIM biologicals as tools against diseases like Type 1 diabetes, Multiple Sclerosis, NMO, and Parkinson's disease. Apart from that, I am interested in the development of novel cancer therapies with a particular focus on Multiple Myeloma, but also investigating other solid tumors. And a last major interest is related to pregnancy and understanding more about the role of Thrombin in terms of cytokine regulation and its functional consequences for trophoblast cells.

Sarah J Butcher

Sarah Butcher did her PhD in EMBL Heidelberg, mentored by Stephen Fuller and Helen Saibil, she carried out postdoctoral training in the MRC Virology Unit in Glasgow, before moving to Helsinki University where she is currently Programme Director of the Structural Biology and Biophysics Programme, Institute of Biotechnology, Head of Instruct-FI National Affiliate Center, Finland & Head of National cryoEM facility. She works on macromolecular structure and assembly, especially of viruses.

Tanya Amanda Camacho-Villegas

Tanya Camacho-Villegas is a Researcher for Mexico in the Medical and Pharmaceutical Biotechnology Unit, CIATEJ, A.C., located in Guadalajara, Jalisco, Mexico (2014-present). She is a member of the Mexican National System of Researchers level I. She works in recombinant protein design, cloning, and production (batch and bioreactor scale). She specializes in phage display for isolating single-domain antibodies such as vNAR´s or peptide isolation with diagnostic applications. Recently, she used the vNAR as an immuno-carrier for NPs for theranostics applications for breast cancer and glioblastomas as models.
She has received a BSc in Biology from the Science Faculty, UABC (2004) and a Marine Biotechnology MSc in CICESE (2007) focusing on the selection and validation of vNARs with anti-cytokines properties as candidates for TNFalpha and VEGF165 neutralizing in humans disorders.
She has received a PhD in Molecular Ecology and Biotechnology from the Marine Science Faculty at UABC (2012). She received a distinction in the Ph.D. dissertation
and fellowships from CONAHCYT for MSc, Ph.D., and Postdoc studies. She was the leader of four projects related to biotechnology companies. She was the author of patents related to vNAR as anti-cytokines or immuno-carriers for drug delivery.

Ruben J. Cauchi

Ruben J. Cauchi is an Associate Professor of Neurogenetics at the University of Malta School of Medicine. He obtained his D.Phil. from the University of Oxford (UK) and did his postdoctoral research at the MRC Laboratory of Molecular Biology, University of Cambridge (UK). Prof. Cauchi heads the ALS/MND Lab at the University of Malta and leads Malta’s National ALS/MND Registry & BioBank, aiming at understanding the cause of motor neuron disease (MND) including amyotrophic lateral sclerosis (ALS) and identify innovative treatments.

Elisabetta Ada Cavalcanti-Adam

E. Ada Cavalcanti-Adam is a research group leader at the Institute of Physical Chemistry, University of Heidelberg and head of Central Scientific Facility “Biomaterials and Molecular Biology” at the Max Planck Institute for Intelligent Systems in Stuttgart. Her main research interest is on extracellular stimuli which guide cell structure and functions with a special focus on the role of growth factors on cell adhesion and migration.

Barbara P Chan

Professor of Biomedical Engineering, Mechanical Engineering at The University of Hong Kong.

Albert Cheng

Albert Cheng obtained his BSc in Biochemistry and MPhil in Biology from Hong Kong University of Science and Technology in 2005 and 2007, respectively. He studied neurotrophin signaling and C. elegans developmental genetics. He then pursued his PhD in Computational & Systems Biology at MIT in the labs of Profs Christopher Burge and Rudolf Jaenisch and worked on various topics on epigenetics, gene regulation and alternative splicing in stem cells, reprogramming, cancer metastasis, erythropoiesis and differentiation. Cheng and colleagues identified H3K27ac as a signature for active enhancers. He analyzed alternative splicing in epithetlial-mesenchymal transition, cancer metastasis as well as erythropoiesis and identified splicing factors regulating these processes. He constructed CRISPR-on, an artificial RNA-guided activator based on CRISPR/Cas. After graduating in 2014, he joined the Jackson Laboratory at Bar Harbor, ME, as one of the first JAX scholars where he continued to work on understanding and improving the CRISPR/Cas technology. In July 2015, he started his own lab as an assistant professor at the Jackson Laboratory for Genomic Medicine campus at Farmington, CT.

Jen-Tsan Chi

Jen-Tsan Ashley Chi, MD PhD is an Associate Professor in the Department of Molecular Genetics and Microbiology and Center for Genomic and Computational Biology. He received his MD from National Taiwan University and his PhD from Stanford University. After his PhD, he was a post-doctoral fellow in Dr. Patrick Brown’s lab in Stanford University focusing on using cDNA microarrays to elucidate the cellular differentiation as well as human pathogenesis. He joined the faculty at MGM and IGSP in 2004.

Dr Chi's research focuses on using functional genomic approaches to investigate the nutrient signaling and stress adaptations of cancer cells when exposed to various nutrient deprivations and microenvironmental stress conditions.